Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Reiteration

Reiteration

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

JMP Securities Reiterates Market Outperform on CTI BioPharma, Maintains $9 Price Target

By Benzinga Newsdesk
February 6, 9:34 AM
JMP Securities analyst Reni Benjamin reiterates CTI BioPharma (NASDAQ:CTIC) with a Market Outperform and maintains $9 price target.

CTIC

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

HC Wainwright & Co. Reiterates Buy on Gracell Biotechnologies, Maintains $12 Price Target

By Benzinga Newsdesk
February 6, 8:55 AM
HC Wainwright & Co. analyst Emily Bodnar reiterates Gracell Biotechnologies (NASDAQ:GRCL) with a Buy and maintains $12 price target.

GRCL

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Barrington Research Reiterates Outperform on 2U, Raises Price Target to $15

By Benzinga Newsdesk
February 6, 6:34 AM
Barrington Research analyst Alexander Paris reiterates 2U (NASDAQ:TWOU) with a Outperform and raises the price target from $9 to $15.

TWOU

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Evercore ISI Group Reiterates Outperform on Apple, Maintains $190 Price Target – Removed From Tactical Outperform List

By Benzinga Newsdesk
February 6, 6:32 AM
Evercore ISI Group analyst Amit Daryanani reiterates Apple (NASDAQ:AAPL) with a Outperform and maintains $190 price target, removed from Tactical Outperform list.

AAPL

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

HC Wainwright & Co. Reiterates Buy on Anavex Life Sciences, Maintains $50 Price Target

By Benzinga Newsdesk
February 6, 5:10 AM
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $50 price target.

AVXL

Read More
3 minute read
  • Analyst Color
  • Analyst Ratings
  • Price Target
  • Reiteration
  • Top Stories
  • Trading Ideas

Amazon’s Retail Strength Outshines AWS Slowdown, Analysts Are Raising Price Targets

By Chris Katje
February 3, 1:38 PM
E-commerce giant Amazon.com, Inc. (NASDAQ: AMZN) reported fourth-quarter financial results after market close Thursday.

AMZN

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target
  • Reiteration

Truist Remains Bullish On Lightspeed Commerce, Naming It An Acquisition Target; Credit Suisse Downgrades The Stock

By Anusuya Lahiri
February 3, 1:16 PM
Credit Suisse analyst Timothy Chiodo downgraded Lightspeed Commerce Inc (NYSE:LSPD) from Outperform to Neutral and lowered the price target from $21 to…

LSPD

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

HC Wainwright & Co. Reiterates Buy on MoonLake, Maintains $28 Price Target

By Benzinga Newsdesk
February 3, 1:09 PM
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates MoonLake (NASDAQ:MLTX) with a Buy and maintains $28 price target.

MLTX

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • General
  • Movers
  • News
  • Price Target
  • Reiteration
  • Restaurants
  • Top Stories
  • Trading Ideas

Why These 4 Starbucks Analysts Are Unphased By Q1 Earnings Miss

By Priya Nigam
February 3, 12:36 PM
Shares of Starbucks Corporation (NASDAQ: SBUX) remained under pressure in early trading on Friday, after the company’s fiscal first-quarter earnings missed expectations.

SBUX

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • Movers
  • News
  • Price Target
  • Reiteration
  • Tech
  • Top Stories
  • Trading Ideas

Why These 4 Alphabet Analysts Are Divided Over Q4 Results

By Priya Nigam
February 3, 12:27 PM
Shares of Alphabet Inc (NASDAQ: GOOGL) remained in the red in early trading on Friday. JMP Securities on Alphabet

GOOGL

Posts pagination

Previous 1 … 308 309 310 … 399 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service